These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 5897212)

  • 1. [Urographic and angiocardiographic studies on dogs with iodamide, a new roentgen contrast medium].
    Boccadoro B
    Arzneimittelforschung; 1965 Mar; 15(3):229-33. PubMed ID: 5897212
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative evaluation of the contrast properties of iodamide and Uromiro (experimental study). Experience in their practical utilization].
    Amosov IS; Nikitina RG; Kugel'mas MK; Rozhinskiĭ MM; Shatov AV
    Vestn Rentgenol Radiol; 1982; (2):40-4. PubMed ID: 7090166
    [No Abstract]   [Full Text] [Related]  

  • 3. [CLINICAL EVALUATION OF VISOTRAST, A NEW TRIIODINATED ROENTGEN CONTRAST MEDIUM OF THE AMIDOTRIZOATE TYPE].
    LIESS G
    Radiol Diagn (Berl); 1963; 51():443-52. PubMed ID: 14122960
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparison of the side effects of urographic contrast media (iothalamate, diatrizoate, iodamide, iopamidol) within the scope of a CT study].
    Stellamor K; Hruby W; Assinger S; Luckner H
    Radiologe; 1984 Oct; 24(10):488-90. PubMed ID: 6505221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conray: a new cardiovascular and urographic contrast medium.
    STEINBERG I; EVANS JA
    Radiology; 1962 Sep; 79():395-400. PubMed ID: 13916675
    [No Abstract]   [Full Text] [Related]  

  • 6. [AMETRIODINIC ACID ("UROMIRO") AS A NEW ROENTGEN CONTRAST MEDIUM. REPORT ON CLINICAL TESTS].
    WUERDINGER H
    Med Welt; 1965 Feb; 7():363-4. PubMed ID: 14268568
    [No Abstract]   [Full Text] [Related]  

  • 7. [Sialoadenomegaly following triiodide administration as a roentgen contrast medium].
    Szántó D
    Orv Hetil; 1979 Mar; 120(9):528. PubMed ID: 424230
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experiences with the new contrast medium iodamide 420 (author's transl)].
    Fráter LL; Száva J; Gaál T; Kertész E
    Rontgenblatter; 1978 Jan; 31(1):38-45. PubMed ID: 622530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Roentgen contrast media. 7. Iodamide, a new contrast medium, biological data].
    Bonati F; Rosati GF; Poletto MG
    Arzneimittelforschung; 1965 Mar; 15(3):222-9. PubMed ID: 5897211
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypaque, a new urographic contrast medium.
    ROOT JC; STRITTMATTER WC
    Am J Roentgenol Radium Ther Nucl Med; 1955 May; 73(5):768-70. PubMed ID: 14361833
    [No Abstract]   [Full Text] [Related]  

  • 11. Ditriokon: a new angiocardiographic medium.
    SANDERSON SS; GROSS KE
    Am J Roentgenol Radium Ther Nucl Med; 1961 Jun; 85():1080-7. PubMed ID: 13746169
    [No Abstract]   [Full Text] [Related]  

  • 12. [Iodamide-300 and 380: evaluation of the results of clinical trials in angiography and urography].
    Absava GI; Rabkin IKh; Rozenshtraukh LS; Krivenko EV
    Vestn Rentgenol Radiol; 1986; (1):74-7. PubMed ID: 3518227
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of angiocardiographic contrast media on left ventricular function.
    Krovetz LJ; Simon AL; Levy RJ; Tift WL
    Johns Hopkins Med J; 1970 Sep; 127(3):172-83. PubMed ID: 5472460
    [No Abstract]   [Full Text] [Related]  

  • 14. Measurement of N tau-methylhistamine concentrations in urine as a parameter for histamine release by radiographic contrast media.
    Keyzer JJ; Udding H; de Vries K
    Diagn Imaging Clin Med; 1984; 53(2):67-72. PubMed ID: 6200265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Urographic effect and methods of elimination of tri-iodated contrast medium (methylglucamine iothalamate)].
    Ventura M; Arena GC; Comoglio A
    Minerva Radiol; 1966; 11(1):89-96. PubMed ID: 5909347
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II studies in urography, cardioangiography and cerebral angiography with iohexol. An evaluation of the clinical trial program and the clinical findings.
    Andrew E; Sveen K; Renaa T; Dahlstrøm K
    Eur J Radiol; 1983 Aug; 3(3):194-201. PubMed ID: 6628397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of hypaque as a urographic medium.
    LLOYD FA; BRAMAN R
    Postgrad Semin Am Urol Assoc North Cent; 1956-1957; ():90-4. PubMed ID: 13567649
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ether as contrast substance in angiocardiography. Experimental observations].
    Testelli MR; Soní J
    Arch Inst Cardiol Mex; 1966; 36(2):149-58. PubMed ID: 5935715
    [No Abstract]   [Full Text] [Related]  

  • 19. Experience with a new urographic agent--hypaque.
    TICE GM
    J Kans Med Soc; 1955 Mar; 56(3):130-2. PubMed ID: 14367986
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of triiodinated contrast media on the blood flow of isolated jejunal loop.
    Bali I; Kovács N; Bálint GA; Kelemen J
    Acta Med Acad Sci Hung; 1980; 37(1):105-8. PubMed ID: 7457012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.